ChalhoubNEWenderferSELevyDM, et al.International consensus for the dosing of corticosteroids in childhood-onset systemic lupus erythematosus with proliferative lupus nephritis. Arthritis Rheumatol. 2022; 74(2): 263–273.
2.
BandhanIHIslamMNAhmadHI, et al.Outcome of low-dose prednisolone use for the induction of remission in lupus nephritis patients. Int J Rheum Dis. 2022; 25(2): 121–130.
3.
ChanWKY. Risk factors for damage in childhood-onset systemic lupus erythematosus in Asians: a case control study. Pediatr Rheumatol Online J2018; 16(1): 56.
4.
Heshin-bekensteinMTrupinLYelinE, et al.Longitudinal disease- and steroid-related damage among adults with childhood-onset systemic lupus erythematosus. Semin Arthritis Rheum. 2019; 49(2): 267–272.
5.
HariharanRKrishnamurthySKaliaperumalS, et al.Paediatrics and international child health incidence and predictive risk factors for ophthalmological complications in children with nephrotic syndrome receiving long-term oral corticosteroids: a cohort study. Paediatr Int Child Health2021; 41(3): 199–205.
6.
MontDMPivecRElmallahRK, et al.High-dose corticosteroid use and risk of hip osteonecrosis: meta-analysis and systematic literature review. J Arthroplasty2015; 30(9): 1506–1512.
7.
WardLM. Glucocorticoid-induced osteoporosis: why kids are different. Front Endocrinol2020; 11: 576.
8.
Pons-EstelBABonfaESorianoER, et al.First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)-Pan-American League of Associations of Rheumatology. Ann Rheum Dis2018; 77: 1549–1557.
Abud-MendozaCGonzález-AmaroR. Are steroids required for induction therapy and relapses in lupus nephritis?Ann Rheum Dis2013; 72(12): e29.
11.
DanzaAGrañaDSotoE, et al.Prednisone and long-term damage in systemic lupus erythematosus: which is the threshold dose? A pilot study. Lupus2022; 31(7): 880–884.
